Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Cancer immunotherapy meets biomaterials.

Literature DB >> 25574635

Cancer immunotherapy meets biomaterials.

Jeffrey S Weber¹, James J Mulé¹.

Abstract

Entities: Disease

Year: 2015 PMID： 25574635 DOI： 10.1038/nbt.3119

Source DB: PubMed Journal: Nat Biotechnol ISSN： 1087-0156 Impact factor: 54.908

× No keyword cloud information.

10 in total

1. Rethinking therapeutic cancer vaccines.

Authors:
Journal: Nat Rev Drug Discov Date: 2009-09 Impact factor: 84.694

2. Long-term survival for patients with non-small-cell lung cancer with intratumoral lymphoid structures.

Authors: Marie-Caroline Dieu-Nosjean; Martine Antoine; Claire Danel; Didier Heudes; Marie Wislez; Virginie Poulot; Nathalie Rabbe; Ludivine Laurans; Eric Tartour; Luc de Chaisemartin; Serge Lebecque; Wolf-Herman Fridman; Jacques Cadranel
Journal: J Clin Oncol Date: 2008-09-20 Impact factor: 44.544

3. In situ regulation of DC subsets and T cells mediates tumor regression in mice.

Authors: Omar A Ali; Dwaine Emerich; Glenn Dranoff; David J Mooney
Journal: Sci Transl Med Date: 2009-11-25 Impact factor: 17.956

4. Foxp3+ T cells induce perforin-dependent dendritic cell death in tumor-draining lymph nodes.

Authors: Alexandre Boissonnas; Alix Scholer-Dahirel; Virginie Simon-Blancal; Luigia Pace; Fabien Valet; Adrien Kissenpfennig; Tim Sparwasser; Bernard Malissen; Luc Fetler; Sebastian Amigorena
Journal: Immunity Date: 2010-02-04 Impact factor: 31.745

5. Plasmacytoid dendritic cells from mouse tumor-draining lymph nodes directly activate mature Tregs via indoleamine 2,3-dioxygenase.

Authors: Madhav D Sharma; Babak Baban; Phillip Chandler; De-Yan Hou; Nagendra Singh; Hideo Yagita; Miyuki Azuma; Bruce R Blazar; Andrew L Mellor; David H Munn
Journal: J Clin Invest Date: 2007-09 Impact factor: 14.808

6. Cancer immunotherapy based on mutation-specific CD4+ T cells in a patient with epithelial cancer.

Authors: Eric Tran; Simon Turcotte; Alena Gros; Paul F Robbins; Yong-Chen Lu; Mark E Dudley; John R Wunderlich; Robert P Somerville; Katherine Hogan; Christian S Hinrichs; Maria R Parkhurst; James C Yang; Steven A Rosenberg
Journal: Science Date: 2014-05-09 Impact factor: 47.728

Review 7. Therapeutic vaccines for cancer: an overview of clinical trials.

Authors: Ignacio Melero; Gustav Gaudernack; Winald Gerritsen; Christoph Huber; Giorgio Parmiani; Suzy Scholl; Nicholas Thatcher; John Wagstaff; Christoph Zielinski; Ian Faulkner; Håkan Mellstedt
Journal: Nat Rev Clin Oncol Date: 2014-07-08 Impact factor: 66.675

8. Biopolymer implants enhance the efficacy of adoptive T-cell therapy.

Authors: Sirkka B Stephan; Alexandria M Taber; Ilona Jileaeva; Ericka P Pegues; Charles L Sentman; Matthias T Stephan
Journal: Nat Biotechnol Date: 2014-12-15 Impact factor: 54.908

9. 12-Chemokine gene signature identifies lymph node-like structures in melanoma: potential for patient selection for immunotherapy?

Authors: Jane L Messina; David A Fenstermacher; Steven Eschrich; Xiaotao Qu; Anders E Berglund; Mark C Lloyd; Michael J Schell; Vernon K Sondak; Jeffrey S Weber; James J Mulé
Journal: Sci Rep Date: 2012-10-24 Impact factor: 4.379

10. Injectable, spontaneously assembling, inorganic scaffolds modulate immune cells in vivo and increase vaccine efficacy.

Authors: Jaeyun Kim; Weiwei Aileen Li; Youngjin Choi; Sarah A Lewin; Catia S Verbeke; Glenn Dranoff; David J Mooney
Journal: Nat Biotechnol Date: 2014-12-08 Impact factor: 54.908

10 in total

9 in total

1. Flexible Macromolecule versus Rigid Particle Retention in the Injected Skin and Accumulation in Draining Lymph Nodes Are Differentially Influenced by Hydrodynamic Size.

Authors: Nathan Andrew Rohner; Susan Napier Thomas
Journal: ACS Biomater Sci Eng Date: 2016-11-18

Review 2. Advances in engineering local drug delivery systems for cancer immunotherapy.

Authors: Peter Abdou; Zejun Wang; Qian Chen; Amanda Chan; Daojia R Zhou; Vivienne Gunadhi; Zhen Gu
Journal: Wiley Interdiscip Rev Nanomed Nanobiotechnol Date: 2020-04-07

3. Co-delivery of tumor antigen and dual toll-like receptor ligands into dendritic cell by silicon microparticle enables efficient immunotherapy against melanoma.

Authors: Motao Zhu; Xilai Ding; Ruifang Zhao; Xuewu Liu; Haifa Shen; Chunmei Cai; Mauro Ferrari; Helen Y Wang; Rong-Fu Wang
Journal: J Control Release Date: 2018-01-08 Impact factor: 9.776

4. Systematic Screening of Chemokines to Identify Candidates to Model and Create Ectopic Lymph Node Structures for Cancer Immunotherapy.

Authors: Yohsuke Yagawa; Mark Robertson-Tessi; Susan L Zhou; Alexander R A Anderson; James J Mulé; Adam W Mailloux
Journal: Sci Rep Date: 2017-11-22 Impact factor: 4.379

5. Tumor-Associated Tertiary Lymphoid Structures: Gene-Expression Profiling and Their Bioengineering.

Authors: Genyuan Zhu; Rana Falahat; Kui Wang; Adam Mailloux; Natalie Artzi; James J Mulé
Journal: Front Immunol Date: 2017-06-30 Impact factor: 7.561

6. Alginate Particles with Ovalbumin (OVA) Peptide Can Serve as a Carrier and Adjuvant for Immune Therapy in B16-OVA Cancer Model.

Authors: Longbao Zhu; Fei Ge; Liangjun Yang; Wanzhen Li; Shenghua Wei; Yugui Tao; Guocheng Du
Journal: Med Sci Monit Basic Res Date: 2017-04-28